Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.
Location: United States, Maryland, Germantown
Employees: 201-500
Founded date: 1998
Investors 3
Mentions in press and media 17
| Date | Title | Description | Source |
| 02.08.2021 | Precigen : to Announce Second Quarter and First Half 2021 Fi... | GERMANTOWN, Md., Aug. 2, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical com... | marketscre... |
| 02.08.2021 | Precigen to Announce Second Quarter and First Half 2021 Fina... | GERMANTOWN, Md., Aug. 2, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical c... | prnewswire... |
| 10.06.2021 | Precigen ActoBio Announces Positive Topline Results from Pha... | GERMANTOWN, Md., June 10, 2021 /PRNewswire/ -- Precigen ActoBio, an innovative clinical-stage biot... | prnewswire... |
| 30.03.2021 | Precigen Announces Departure of Chief Financial Officer | GERMANTOWN, Md., March 30, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specia... | prnewswire... |
| 30.03.2021 | PRECIGEN, INC. Precigen : Announces Departure of Chief Fina... | GERMANTOWN, Md., March 30, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company speciali... | marketscre... |
| 23.03.2021 | Precigen Announces First Patient Dosed for PRGN-2012 AdenoVe... | GERMANTOWN, Md., March 23, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specia... | prnewswire... |
| 18.03.2021 | Precigen Receives FDA Orphan Drug Designation for PRGN-2012 ... | GERMANTOWN, Md., March 18, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specia... | prnewswire... |
| 01.03.2021 | Precigen Reports Fourth Quarter and Full Year 2020 Financial... | GERMANTOWN, Md., March 1, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical ... | prnewswire... |
| 22.02.2021 | Precigen to Announce Fourth Quarter and Full Year 2020 Finan... | GERMANTOWN, Md., Feb. 22, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical ... | prnewswire... |
| 26.01.2021 | Precigen Announces Closing of Public Offering of Common Stoc... | GERMANTOWN, Md., Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the c... | prnewswire... |
Show more